Statin Therapy for Primary Prevention in the Elderly and Its Association with New-Onset Diabetes, Cardiovascular Events, and All-Cause Mortality.

The American Journal of Medicine
Gil LavieOrna Reges

Abstract

This study assessed associations of the use of statins for primary prevention with cardiovascular outcomes among adults ages ≥70 years. In a retrospective population-based cohort study, new users of statins without cardiovascular disease or diabetes mellitus were stratified by ages ≥70 years and <70 years. Using a time-dependent approach, adherence to statins was evaluated according to the proportion of days covered: <25%, 25%-50%, 50%-75%, and ≥75%. We assessed associations of statin therapy with increased risk of new-onset diabetes mellitus and with decreased risks of major adverse cardiovascular events and all-cause mortality. Of 42,767 new users of statins, 5970 (14%) were ages ≥70 years. The incident rates of major adverse cardiovascular events, all-cause mortality, and new-onset diabetes mellitus in the highest to lowest proportion of days covered categories were 16.9%, 16.7%, and 9.4% and 6.3%, 1.7%, and 9.4%, respectively. For the older group, the adjusted hazard ratios of major adverse cardiovascular events and mortality were significantly decreased for the highest adherence group (proportion of days covered ≥75%): 0.71 (0.57-0.88) and 0.68 (0.54-0.84), respectively. The respective hazard ratios were less favorable for...Continue Reading

References

Oct 31, 2003·American Journal of Epidemiology·Wayne A Ray
Jan 5, 2008·Journal of the American College of Cardiology·Jonathan AfilaloMark J Eisenberg
Jan 29, 2013·The American Journal of Cardiology·Eliano Pio NavareseJacek Kubica
Sep 13, 2013·The Cochrane Database of Systematic Reviews·Rod S TaylorShah Ebrahim
Nov 19, 2013·Journal of the American College of Cardiology·Neil J StoneUNKNOWN American College of Cardiology/American Heart Association Task Force on Practice Guidelines
May 29, 2014·Current Opinion in Cardiology·Sophia ZoungasJohn McNeil
Nov 18, 2014·Population Health Metrics·Tomas KarpatiRan D Balicer
Apr 16, 2016·Journal of the American College of Cardiology·Michael W RichUNKNOWN American College of Cardiology; and American Geriatrics Society
Nov 14, 2016·JAMA : the Journal of the American Medical Association·UNKNOWN US Preventive Services Task ForceMichael P Pignone
Jan 6, 2018·Journal of the American College of Cardiology·Martin Bødtker Mortensen, Erling Falk
Jul 11, 2018·Drugs & Aging·Wade ThompsonDorte Ejg Jarbøl
Jan 21, 2019·The American Journal of Medicine·Julien BezinAntoine Pariente
Mar 25, 2019·The Journal of Clinical Endocrinology and Metabolism·Oscar J PonceMohammad Hassan Murad
Sep 11, 2019·European Heart Journal·François MachUNKNOWN ESC Scientific Document Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.